Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitlePhase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsDaruka Mahadevan